Clearside biomedical, inc. (CLSD)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Dec'15Dec'14
Assets
Current assets:
Cash and cash equivalents

20,930

22,595

22,551

26,174

32,950

8,043

15,841

35,185

84,834

9,224

16,289

16,675

22,989

34,824

36,876

55,279

20,283

8,269

Short-term investments

-

-

-

-

1,988

32,835

49,101

49,245

16,221

28,416

36,338

49,360

54,462

48,807

20,043

-

-

-

Prepaid expenses

892

1,139

1,468

1,659

497

2,049

3,247

2,391

2,168

1,445

712

675

2,511

396

662

737

159

47

Other current assets

1,683

1,485

27

60

33

17

-

-

6

116

141

292

522

290

73

17

40

7

Total current assets

23,505

25,219

24,046

27,893

35,468

42,944

68,189

86,821

103,229

39,201

53,480

67,002

80,484

84,317

57,654

56,033

20,482

8,323

Property and equipment, net

551

541

655

708

755

790

778

791

838

885

932

963

1,010

94

110

124

156

205

Operating lease right-of-use asset

627

656

806

867

925

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

410

1,750

Restricted cash

360

360

360

360

360

360

360

360

360

360

360

360

360

360

-

-

-

-

Other assets

-

-

-

26

26

26

54

44

35

47

103

90

104

42

7

7

7

21

Total assets

25,043

26,776

25,867

29,854

37,534

44,120

69,381

88,016

104,462

40,493

54,875

68,415

81,958

84,813

57,771

56,164

21,055

10,299

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable

1,633

1,280

1,429

2,227

5,258

6,869

11,910

8,372

6,744

5,384

5,075

3,732

4,716

2,594

1,347

2,366

1,469

1,257

Accrued liabilities

1,492

2,930

2,698

2,863

4,520

2,923

2,744

2,368

3,697

4,716

4,004

1,639

1,541

2,791

1,556

1,940

1,985

1,157

Current portion of long-term debt

5,183

1,333

5,833

2,222

1,389

556

-

-

3,200

3,200

2,400

1,600

800

-

-

2,400

1,733

-

Current portion of operating lease liabilities

363

360

483

504

499

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of deferred rent

-

-

-

-

-

128

211

206

202

199

196

145

109

3

-

7

-

10

Deferred revenue

5,100

5,000

-

-

-

-

-

-

-

-

-

-

-

-

-

20

-

-

Other current liabilities

-

-

375

225

-

-

-

-

-

20

20

20

20

20

25

-

9

-

Total current liabilities

13,771

10,903

10,818

8,041

11,666

10,476

14,865

10,946

13,843

13,519

11,695

7,136

7,186

5,408

2,928

6,733

5,196

2,424

Long-term debt

-

3,819

4,329

7,877

8,647

9,419

9,911

9,848

4,107

4,809

5,503

6,196

6,891

7,586

7,489

3,286

4,243

-

Operating lease liabilities

832

897

961

1,035

1,130

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11

Deferred rent

-

-

-

-

-

605

524

550

581

610

637

607

563

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

140

145

150

155

160

165

170

700

200

Other non-current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

251

79

261

42

Total liabilities

14,603

15,619

16,108

16,953

21,443

20,500

25,300

21,344

18,531

19,078

17,980

14,089

14,795

13,154

10,833

10,268

10,400

2,677

Commitments and contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

-

Total convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

47,314

26,835

Stockholders’ equity:
Preferred stock, $0.001 par value; 10,000,000 shares authorized and no shares issued at March 31, 2020 and December 31, 2019

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

-

Common stock, $0.001 par value; 100,000,000 shares authorized at March 31, 2020 and December 31, 2019; 44,868,558 and 44,413,372 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

45

44

41

38

37

32

32

32

32

25

25

25

25

25

21

20

3

2

Additional paid-in capital

250,963

248,770

244,279

240,888

238,345

230,475

229,293

228,007

226,567

145,618

144,605

143,715

142,777

136,892

102,481

95,790

2,701

2,509

Accumulated deficit

-240,568

-237,657

-234,561

-228,025

-222,291

-206,887

-185,240

-161,368

-140,667

-124,220

-107,727

-89,391

-75,618

-65,245

-55,559

-49,914

-39,363

-21,724

Accumulated other comprehensive loss

-

-

-

-

-

-

-4

1

-1

-8

-8

-23

-21

-13

-5

-

-

-

Total stockholders’ equity

10,440

11,157

9,759

12,901

16,091

23,620

44,081

66,672

85,931

21,415

36,895

54,326

67,163

71,659

46,938

45,896

-36,659

-19,213

Total liabilities and stockholders’ equity

25,043

26,776

25,867

29,854

37,534

44,120

69,381

88,016

104,462

40,493

54,875

68,415

81,958

84,813

57,771

56,164

21,055

10,299